BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3314259)

  • 1. Characterization of proteins, insoluble at low temperature, produced by Clostridium botulinum type C and C. subterminale. Their antigenic relationship with a similar protein synthesized by C. botulinum type G.
    Giménez JA; Vita N; Giménez DF; Paladini AC
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):45-56. PubMed ID: 3314259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of a protein, insoluble at low temperature, produced by Clostridium botulinum type G.
    Giménez JA; Cascone O; Biscoglio de Jimenez Bonino MJ; Paladini AC
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Aug; 262(2):179-88. PubMed ID: 3538716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a wall protein antigen from Clostridium botulinum type A.
    Takumi K; Takeoka A; Kawata T
    Infect Immun; 1983 Mar; 39(3):1346-53. PubMed ID: 6341236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the common antigens of Clostridium botulinum, C. sporogenes and C. novyi by an enzyme-linked immunosorbent assay and electroblot transfer.
    Poxton IR
    J Gen Microbiol; 1984 Apr; 130(4):975-81. PubMed ID: 6376703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescent study of the spore antigens of proteolytic strains of Clostridium botulinum.
    Princewill TJ
    J Hyg (Lond); 1979 Aug; 83(1):1-9. PubMed ID: 379206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical characterization of cell wall protein antigen purified from the cell wall autolysate of Clostridium botulinum type A.
    Takumi K; Kawata T
    Jpn J Microbiol; 1975 Feb; 19(1):1-6. PubMed ID: 51110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilocus enzyme electrophoresis of Clostridium argentinense (Clostridium botulinum toxin type G) and phenotypically similar asaccharolytic clostridia.
    Altwegg M; Hatheway CL
    J Clin Microbiol; 1988 Nov; 26(11):2447-9. PubMed ID: 3069865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme.
    Sonnabend WF; Sonnabend UP; Krech T
    Appl Environ Microbiol; 1987 Aug; 53(8):1880-4. PubMed ID: 3116935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of shared antigens in the genus Clostridium by an enzyme-linked immunosorbent assay.
    Poxton IR; Byrne MD
    J Med Microbiol; 1984 Apr; 17(2):171-6. PubMed ID: 6323714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent-antibody reagents for the identification of Clostridium botulinum.
    Glasby C; Hatheway CL
    J Clin Microbiol; 1983 Dec; 18(6):1378-83. PubMed ID: 6361053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration and characterization of the cell wall carbohydrate and protein antigens from Clostridium botulinum type E Saroma.
    Takumi K; Nagao S; Takeoka A
    Microbiol Immunol; 1991; 35(1):27-37. PubMed ID: 1908039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Clostridium botulinum, Clostridium argentinense, and related organisms by cellular fatty acid analysis.
    Ghanem FM; Ridpath AC; Moore WE; Moore LV
    J Clin Microbiol; 1991 Jun; 29(6):1114-24. PubMed ID: 1864927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryoprotein produced by Clostridium botulinum type G.
    Ciccarelli AS; Giménez DF
    Infect Immun; 1972 Jun; 5(6):985-6. PubMed ID: 4564408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    Appl Microbiol; 1971 Feb; 21(2):295-9. PubMed ID: 4927406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.